CARLSBAD, Calif., Mar 17, 2010 (GlobeNewswire via COMTEX News Network) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions affecting the aging spine, announced today that at a special meeting of stockholders held on March 16, 2010, its stockholders approved the issuance of 24,000,000 shares of the Company's common stock in connection with the acquisition of Scient'x Groupe SAS. Approximately 78% of the shares of the Company's common stock that were eligible to vote on the matter were voted. Of the shares that were voted, over 99% voted in favor of the transaction. The Company expects the closing of the transaction to be completed prior to the end of the first quarter.
"We are pleased that our stockholders have overwhelmingly supported this transaction, which we believe will create a company with global scale and presence, as well as a unique and differentiated product portfolio," stated Dirk Kuyper, the Company's President and CEO.
The transaction remains subject to customary closing conditions.
